NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -17.48% | -17.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.48% | -17.33% | |||
| Cost of Revenue | -13.88% | -5.22% | |||
| Gross Profit | -33.61% | -201.91% | |||
| SG&A Expenses | 13.67% | 1.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.11% | -2.35% | |||
| Operating Income | -15.40% | -23.05% | |||
| Income Before Tax | 3.81% | -45.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.81% | -45.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.81% | -45.05% | |||
| EBIT | -15.40% | -23.05% | |||
| EBITDA | -16.49% | -24.30% | |||
| EPS Basic | 5.78% | -43.41% | |||
| Normalized Basic EPS | -13.73% | -23.69% | |||
| EPS Diluted | -10.16% | -38.89% | |||
| Normalized Diluted EPS | -12.75% | -23.69% | |||
| Average Basic Shares Outstanding | 2.08% | 1.15% | |||
| Average Diluted Shares Outstanding | 3.00% | 1.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||